Attract talent


1 Follower


OncoSec is a biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. Through its proprietary DNA gene transfer technology, OncoSec seeks to deliver safer and more effective cancer treatments that can provide long-term benefits for patients who have limited or no available treatment options.


Add photos to showcase OncoSec’s culture


Add OncoSec’s values

Insider experiences

Share your experience of working at OncoSec

Kevin Smith
Interim President & CEO
Sandra Aung
SVP, Chief Clinical Development Officer
Joe Smith
VP, Business Development
Jeff Silverman
VP, Product Engineering
Bridget O'Keeffe
VP, Clinical Development
Rob Schinagl
VP, Program & Alliance Management

Add your teams to show how people work together at OncoSec

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.